Allogeneic Transplantation
Myeloproliferative Neoplasms Trials (MPN: ET, MF, PV)
COMIRB: 22-0305
A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera
Principal Investigator: Brandon McMahon
Eligibility: Ages ≥ 18; Diagnosed polycythemia vera; ECOG of ≤2
COMIRB: 22-0130
A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants with Myelofibrosis and Other Advanced Myeloid Neoplasms
PI: Brandon McMahon
Eligibility: Ages ≥ 18; Relapsed or refractory MF, MDS, or MDS/MPN (Part 1); ECOG of ≤2
Request an Appointment
If you would like to schedule an appointment, please give us a call.
Our intake coordinator will help you navigate the process of becoming a new patient including helping you obtain the necessary referrals, get the necessary medical records transferred, and coordinate care with your existing physicians. We are available to answer your questions about our clinic, your treatment, and participation in ongoing clinical trials.